Literature DB >> 10896014

Managing delayed-onset muscle soreness: lack of effect of selected oral systemic analgesics.

P Barlas1, J A Craig, J Robinson, D M Walsh, G D Baxter, J M Allen.   

Abstract

OBJECTIVE: To investigate the efficacy of commonly available analgesics in the management of delayed-onset muscle soreness over an 11-day period.
DESIGN: Double-blind, placebo-controlled randomized trial.
SETTING: University laboratory. PARTICIPANTS: Sixty healthy volunteers (30 men, 30 women) with no current arm pain or pathology completed the experimental procedure.
INTERVENTIONS: Subjects were randomly allocated to one of five experimental groups: control; placebo; aspirin (900 mg); codeine (60 mg); and paracetamol (1000 mg) (n = 12 in all groups). Delayed soreness was induced in the nondominant elbow flexors using a standardized exercise protocol of repeated eccentric contractions. MAIN OUTCOME MEASURES: Pain (visual analogue scale; McGill pain questionnaire [MPQ]), range of extension, flexion and resting angle (universal goniometer), and mechanical pain threshold (pressure algometer). Measurements were taken before and after drug administration each day, except for the MPQ, which was completed on the first and third days of the experiment.
RESULTS: Analysis of results using repeated-measures analysis of variance and relevant post hoc tests provided no evidence of the effectiveness of any of the preparations.
CONCLUSION: There is no beneficial effect from the medications, at least at the doses stated, in the management of delayed-onset muscle soreness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896014     DOI: 10.1053/apmr.2000.6277

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

1.  The use of thermal infra-red imaging to detect delayed onset muscle soreness.

Authors:  Hani H Al-Nakhli; Jerrold S Petrofsky; Michael S Laymon; Lee S Berk
Journal:  J Vis Exp       Date:  2012-01-22       Impact factor: 1.355

Review 2.  Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 3.  Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury.

Authors:  Angela Baldwin Lanier
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Repeated muscle injury as a presumptive trigger for chronic masticatory muscle pain.

Authors:  Dean Dessem; Richard M Lovering
Journal:  Pain Res Treat       Date:  2011-06-12

5.  Eccentric exercise and delayed onset muscle soreness of the quadriceps induce adjustments in agonist-antagonist activity, which are dependent on the motor task.

Authors:  C Vila-Chã; H Hassanlouei; D Farina; D Falla
Journal:  Exp Brain Res       Date:  2011-11-18       Impact factor: 1.972

6.  Effects of tender point acupuncture on delayed onset muscle soreness (DOMS)--a pragmatic trial.

Authors:  Kazunori Itoh; Hideki Ochi; Hiroshi Kitakoji
Journal:  Chin Med       Date:  2008-11-25       Impact factor: 5.455

7.  Effects of alfa-hydroxy-isocaproic acid on body composition, DOMS and performance in athletes.

Authors:  Antti A Mero; Tuomo Ojala; Juha J Hulmi; Risto Puurtinen; Tuomo Am Karila; Timo Seppälä
Journal:  J Int Soc Sports Nutr       Date:  2010-01-05       Impact factor: 5.150

8.  Delayed-onset muscle soreness: a pilot study to assess analgesic study design features.

Authors:  Neil Singla; Paul J Desjardins; Evelyn B Cosca; Cherri Parulan; Anne Arriaga; Kelly C Poole; Dan M Batz; Phoebe D Chang
Journal:  Pain       Date:  2015-06       Impact factor: 7.926

9.  Jakyakgamcho-tang in the relief of delayed-onset muscle soreness in healthy adults: study protocol for a randomized, double-blind, placebo-controlled, crossover design clinical trial.

Authors:  Kyungsun Han; Ojin Kwon; So-Young Jung; In-Hwa Park; Man-Suk Hwang; Sun-Young Park; Eui-Hyoung Hwang; Jun-Hwan Lee
Journal:  Trials       Date:  2020-02-21       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.